טוען...
WEScover: selection between clinical whole exome sequencing and gene panel testing
BACKGROUND: Whole exome sequencing (WES) is widely adopted in clinical and research settings; however, one of the practical concerns is the potential false negatives due to incomplete breadth and depth of coverage for several exons in clinically implicated genes. In some cases, a targeted gene panel...
שמור ב:
| הוצא לאור ב: | BMC Bioinformatics |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139020/ https://ncbi.nlm.nih.gov/pubmed/34016036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-021-04178-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|